Glutamine: Clinical Trials

4 trials of Glutamine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 terminated. 4 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 34Terminated 4
Phase 21Terminated 1

Follow Glutamine: new trials by email Literature Review of Glutamine trials Research Report on Glutamine

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Randomized Trial of Glutamine in Patients With Mucositis or Esophagitis
Placebo, Glutamine, Questionnaires - Advanced Cancers
Phase 3TerminatedM.D. Anderson Cancer Center772014-07-102022-06-15
The CRISIS Prevention Study
Metoclopramide, Zinc, Glutamine - Sepsis
Phase 3TerminatedMichael Dean2932007-04-012013-04-18
Enteral Glutamine in Critical Illness
Glutamine - Critical Illness, Sepsis
Phase 2 / Phase 3TerminatedChristiana Care Health Services202006-05-012008-03-13
S9908: Glutamine in Treating Mucositis Caused by Radiation Therapy in Patients With Newly Diagnosed Cancer of the Mouth or Throat
glutamine, radiation therapy, l-glutamine placebo - Cancer-related Problem/Condition, Head and Neck Cancer
Phase 3TerminatedSWOG Cancer Research Network232001-11-012015-11-18

Conditions studied

Sepsis (2)  ·  Critical Illness (1)  ·  Esophagitis (1)  ·  Head and Neck Neoplasms (1)  ·  Mucositis (1)  ·  Pain (1)  ·  Radiation Injuries (1)  ·  Respiratory Insufficiency (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)

Sponsors

Christiana Care Health Services (1)  ·  M.D. Anderson Cancer Center (1)  ·  Michael Dean (1)  ·  SWOG Cancer Research Network (1)

Countries

United States (4)  ·  Canada (1)

Top investigators

Aung Naing, MD (1)  ·  Joseph Carcillo, MD (1)  ·  Michael DePietro, M.D. (1)  ·  V. S. Klimberg, MD (1)

Results publications

PMID 22079954, PMID 33580845

NIH funding

U10CA037429 (1)